Literature DB >> 26308946

Randomized Controlled Trial to Determine the Impact of Probiotic Administration on Colonization With Multidrug-Resistant Organisms in Critically Ill Patients.

Jennie H Kwon1, Kerry M Bommarito1, Kimberly A Reske1, Sondra M Seiler1, Tiffany Hink1, Hilary M Babcock1, Marin H Kollef2, Victoria J Fraser1, Carey-Ann D Burnham3, Erik R Dubberke1.   

Abstract

This was a randomized controlled pilot study of Lactobacillus rhamnosus GG versus standard of care to prevent gastrointestinal multidrug-resistant organism colonization in intensive care unit patients. Among 70 subjects, there were no significant differences in acquisition or loss of any multidrug-resistant organisms (P>.05) and no probiotic-associated adverse events.

Entities:  

Mesh：

Year:  2015        PMID： 26308946      PMCID： PMC4689597          DOI： 10.1017/ice.2015.195

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  10 in total

Review 1.  The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens.

Authors:  Curtis J Donskey
Journal:  Clin Infect Dis       Date:  2004-06-25       Impact factor: 9.079

Review 2.  Probiotics in the critically ill: a systematic review of the randomized trial evidence.

Authors:  Elaine O Petrof; Rupinder Dhaliwal; William Manzanares; Jennie Johnstone; Deborah Cook; Daren K Heyland
Journal:  Crit Care Med       Date:  2012-12       Impact factor: 7.598

Review 3.  Impact of the administration of probiotics on mortality in critically ill adult patients: a meta-analysis of randomized controlled trials.

Authors:  Damien Barraud; Pierre-Edouard Bollaert; Sébastien Gibot
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

4.  Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.

Authors:  Marie-Laurence Lambert; Carl Suetens; Anne Savey; Mercedes Palomar; Michael Hiesmayr; Ingrid Morales; Antonella Agodi; Uwe Frank; Karl Mertens; Martin Schumacher; Martin Wolkewitz
Journal:  Lancet Infect Dis       Date:  2010-12-02       Impact factor: 25.071

5.  Effects of probiotics on acquisition and spread of multiresistant enterococci.

Authors:  Marieke J A de Regt; Rob J L Willems; Ronald J Hené; Peter D Siersema; Harald J J Verhaar; Titia E M Hopmans; Marc J M Bonten
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

6.  A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimens.

Authors:  Tiffany Hink; Carey-Ann D Burnham; Erik R Dubberke
Journal:  Anaerobe       Date:  2012-12-13       Impact factor: 3.331

7.  Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea.

Authors:  Sue Plummer; Mark A Weaver; Janine C Harris; Phillipa Dee; John Hunter
Journal:  Int Microbiol       Date:  2004-03       Impact factor: 2.479

8.  Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial.

Authors:  Stephen J Allen; Kathie Wareham; Duolao Wang; Caroline Bradley; Hayley Hutchings; Wyn Harris; Anjan Dhar; Helga Brown; Alwyn Foden; Michael B Gravenor; Dietrich Mack
Journal:  Lancet       Date:  2013-08-08       Impact factor: 79.321

Review 9.  Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.

Authors:  Joshua Z Goldenberg; Stephanie S Y Ma; Jane D Saxton; Mark R Martzen; Per O Vandvik; Kristian Thorlund; Gordon H Guyatt; Bradley C Johnston
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31

10.  The rising problem of antimicrobial resistance in the intensive care unit.

Authors:  Nele Brusselaers; Dirk Vogelaers; Stijn Blot
Journal:  Ann Intensive Care       Date:  2011-11-23       Impact factor: 6.925
  10 in total
  8 in total

1.  Predominance of Lactobacillus spp. Among Patients Who Do Not Acquire Multidrug-Resistant Organisms.

Authors:  Rafael Araos; Albert K Tai; Graham M Snyder; Martin J Blaser; Erika M C D'Agata
Journal:  Clin Infect Dis       Date:  2016-06-28       Impact factor: 9.079

2.  Intestinal colonization with resistant bacteria: a prognostic marker of mortality in decompensated cirrhosis.

Authors:  S Pouriki; G Vrioni; H Sambatakou; A Alexopoulou; L Vasilieva; I Mani; A Tsakris; S P Dourakis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-09-30       Impact factor: 3.267

Review 3.  The Role of Probiotics, Prebiotics and Synbiotics in Combating Multidrug-Resistant Organisms.

Authors:  Alexander M Newman; Mehreen Arshad
Journal:  Clin Ther       Date:  2020-08-12       Impact factor: 3.393

4.  The Use of Microbiome Restoration Therapeutics to Eliminate Intestinal Colonization With Multidrug-Resistant Organisms.

Authors:  Srinivasa Nithin Gopalsamy; Michael H Woodworth; Tiffany Wang; Cynthia T Carpentieri; Nirja Mehta; Rachel J Friedman-Moraco; Aneesh K Mehta; Christian P Larsen; Colleen S Kraft
Journal:  Am J Med Sci       Date:  2018-08-29       Impact factor: 2.378

Review 5.  Bacterial, Gut Microbiome-Modifying Therapies to Defend against Multidrug Resistant Organisms.

Authors:  Amy Feehan; Julia Garcia-Diaz
Journal:  Microorganisms       Date:  2020-01-24

6.  Probiotics and intestinal decolonization of antibiotic-resistant microorganisms; A reality or fantasy?

Authors:  Mohsen Karbalaei; Masoud Keikha
Journal:  Ann Med Surg (Lond)       Date:  2022-07-31

Review 7.  Impact of microbiome-based interventions on gastrointestinal pathogen colonization in the intensive care unit.

Authors:  Alexa Choy; Daniel E Freedberg
Journal:  Therap Adv Gastroenterol       Date:  2020-07-17       Impact factor: 4.409

8.  Proof-of-concept trial of the combination of lactitol with Bifidobacterium bifidum and Lactobacillus acidophilus for the eradication of intestinal OXA-48-producing Enterobacteriaceae.

Authors:  Juan Carlos Ramos-Ramos; Fernando Lázaro-Perona; José Ramón Arribas; Julio García-Rodríguez; Jesús Mingorance; Guillermo Ruiz-Carrascoso; Alberto M Borobia; José Ramón Paño-Pardo; Rafael Herruzo; Francisco Arnalich
Journal:  Gut Pathog       Date:  2020-04-07       Impact factor: 4.181
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.